Short Interest in Agape ATP Corporation (NASDAQ:ATPC) Decreases By 46.0%

Agape ATP Corporation (NASDAQ:ATPC) was the target of a significant decrease in short interest in the month of May. As of May 15th, there was short interest totaling 5,215 shares, a decrease of 46.0% from the April 30th total of 9,663 shares. Approximately 0.5% of the company’s shares are sold short. Based on an average daily trading volume, of 67,588 shares, the short-interest ratio is presently 0.1 days.

Agape ATP Price Performance

NASDAQ:ATPC opened at $4.87 on Monday. The company has a market cap of $4.87 million, a P/E ratio of -3.66 and a beta of 0.05. Agape ATP has a fifty-two week low of $1.72 and a fifty-two week high of $99.50. The firm’s 50 day moving average is $2.67 and its two-hundred day moving average is $12.49.

Agape ATP (NASDAQ:ATPC) last posted its quarterly earnings results on Friday, May 15th. The company reported ($0.33) earnings per share for the quarter. The company had revenue of $0.27 million for the quarter. Agape ATP had a negative return on equity of 8.43% and a negative net margin of 125.89%.

Hedge Funds Weigh In On Agape ATP

An institutional investor recently raised its position in Agape ATP stock. Citadel Advisors LLC boosted its stake in shares of Agape ATP Corporation (NASDAQ:ATPC) by 95.7% during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 65,130 shares of the company’s stock after purchasing an additional 31,849 shares during the period. Citadel Advisors LLC owned approximately 0.13% of Agape ATP worth $82,000 at the end of the most recent reporting period. 0.01% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

Several equities analysts recently issued reports on ATPC shares. Weiss Ratings reissued a “sell (e+)” rating on shares of Agape ATP in a research note on Friday, May 22nd. Wall Street Zen raised shares of Agape ATP from a “sell” rating to a “hold” rating in a research note on Sunday, April 12th. One equities research analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, the company currently has a consensus rating of “Sell”.

Agape ATP Company Profile

Agape ATP Corporation, an investment holding company, supplies health and wellness products and health solution advisory services in Malaysia. It offers four series of programs that consist of various services and products under the ATP Zeta Health Program, ÉNERGÉTIQUE, BEAUNIQUE, and E.A.T.S. names. The company's products include ATP1s Survivor Select that contains various essential nutrients required by the human body to maintain normal metabolism; ATP3 Ionized Cal-Mag, a calcium and magnesium minerals supplement; ATP4 Omega Blend, an oil blend that provides a bio-effective balance of essential fatty acids, omega 3, and omega 6; ATP5 BetaMaxx, a natural immune enhancer; AGN-Vege Fruit Fiber, a nutrition-based formulation for intestines and stomach; AGP1-Iron to improve iron deficiency anemia; and YFA-Young Formula, an anti-aging and youthful maintenance supplement.